Accell Clinical Research

Accell Clinical Research

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Accell Clinical Research is a private, European CRO with a strong operational footprint in Eastern Europe and the CIS region, offering full-service clinical trial management. It differentiates itself through deep regional expertise, a dedicated oncology subdivision (Accell Oncology), and claims superior patient enrollment rates compared to global averages in several therapeutic areas. The company targets sponsors seeking faster recruitment and cost-effective trial execution in its core geographies, operating as a revenue-generating services business.

OncologyCardiovascularEndocrinologyImmunologyHematology

Technology Platform

Operational network and regional expertise for clinical trial management in Eastern Europe/CIS, with a dedicated oncology subdivision (Accell Oncology) and claimed superior patient enrollment metrics.

Opportunities

Capitalizes on faster patient recruitment and lower operational costs in Eastern Europe/CIS compared to saturated Western markets.
Growing demand for specialized CROs, particularly in complex oncology trials, and the trend towards clinical trial globalization present significant growth potential.

Risk Factors

High exposure to geopolitical instability and economic sanctions in its core regions, especially Russia.
Faces intense competition from global CROs and relies on maintaining its reputation for superior enrollment speed.
Revenue is vulnerable to cyclical shifts in pharmaceutical R&D spending.

Competitive Landscape

Competes against large, global full-service CROs (e.g., IQVIA, PPD, ICON) and other regional CROs specializing in Eastern Europe. Differentiates through deep local expertise, a dedicated oncology team, and data claiming significantly faster patient enrollment rates in its geographic focus area.